Leadership - Ontario Institute for Cancer Research

;

About

Leadership

Collaboration is a key value at the heart of OICR.

Collaboration is an integral driver of our leadership team, which brings together experts with diverse voices, backgrounds and skill sets to lead our shared pursuit of world-class translational cancer research together. OICR is overseen by a volunteer Board of Directors, which is responsible for the success and sustainability of the Institute and the overall governance of the affairs of the corporation.

OICR has joined the 50 – 30 Challenge. This is a challenge to increase the representation and inclusion of diverse groups within the workplace

Executive

Christine Williams, PhD

Christine Williams, PhD

Acting President and Head, Implementation Science

Lincoln Stein, MD, PhD

Lincoln Stein, MD, PhD

Acting Scientific Director and Head, Adaptive Oncology

Rebecca Tamarchak, PhD

Rebecca Tamarchak, PhD

Head of Strategy, Governance and Partnerships

Jeanette Dias D’Souza, CPA, CA, ICD.D

Jeanette Dias D’Souza, CPA, CA, ICD.D

Senior Vice President, Corporate Services and Group Chief Financial Officer of OICR and FACIT

OICR Executive Advisors

CEO, Global Alliance for Genomics and Health (GA4GH)

Board of Directors

Susan Fitzpatrick (Chair)

Former Head, Canadian Drug Agency Transition Office at Health Canada

Laurie Harrison (Vice Chair)

Former Vice President, Finance and Chief Financial Officer, Hospital for Sick Children

Jason Berman, MD

Chief Executive Officer and Scientific Director, Children’s Hospital of Eastern Ontario (CHEO); Research Institute and Vice President Research, CHEO

Jennifer Chan, MD

Director of the Arnie Charbonneau Cancer Institute and an Associate Professor in the Department of Pathology & Laboratory Medicine, at the University of Calgary

Rodney Cheung, P. Eng, EMBA

Global Chief Information Officer (CIO), BGIS

Drenth Consultants Inc.

General Counsel, Intellectual Property Ontario

Principal, Innovation Strategy and Capital Consultancy

Professor of Taxation and a Schulich Research Excellence Fellow at the Schulich School of Business, York University

Nancy Ross, PhD

Vice-Principal Research, Queen’s University

Director, Rosalind and Morris Goodman Cancer Institute at McGill University and Professor of Immunology

Senior Director, Clinical Development, Alpha-9 Oncology

Bradly G. Wouters, PhD

Executive Vice President, Science and Research, University Health Network

Scientific Advisory Board

Marco Marra (Chair)

UBC Killam Professor
Department of Medical Genetics, University of British Columbia
Distinguished Scientist, BC Cancer Research Institute
Terry Fox Leader in Cancer Genome Science

Hakim Djaballah, PhD

President and CEO
Keren Therapeutics

Olivera J. Finn, PhD

Chair and Professor, Department of Immunology
University of Pittsburgh School of Medicine
Director, Immunology Program
University of Pittsburgh Cancer Institute

Mark Lawler, PhD

Associate Director, HDR UK
Queens University Belfast

Sherene Loi, MBBS (Hons), PhD, FRACP, FAHMS, GAICD

- Consultant Medical Oncologist, Breast Unit
  Head, Translational Breast Cancer Genomics and Therapeutics Lab (Loi Lab)
  Breast Stream Lead, Parkville Precinct Cancer Clinical Trials Unit (PCCTU)
  Peter MacCallum Cancer Centre
  University of Melbourne

Edward F. Patz, MD

James and Alice Chen Distinguished Professor of Radiology
Professor of Radiology
Professor in Pathology
Professor in Pharmacology & Cancer Biology
Member of the Duke Cancer Institute